| Literature DB >> 11570843 |
X G Chen1, Y Gong, Z R Lun, M C Fung.
Abstract
Surface antigen 1 (SAG1) of Toxoplasma gondii is a good candidate for diagnosis and vaccine development, but recombinant SAG1 produced in Escheichia coli often loses its specific immunogenicity due to the incorrect folding. In the present study, a truncated SAG1 was highly expressed in E. coli as a fusion protein, about 30% of the total protein of the cell lysate. After a simple purification and refolding procedure, purified rSAG1 can be recognized by human Toxoplasma-infective serum, and ELISA kits constructed by rSAG1 can sensitively and specifically detect toxoplasma infection. Copyright 2001 Academic Press.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11570843 DOI: 10.1006/prep.2001.1483
Source DB: PubMed Journal: Protein Expr Purif ISSN: 1046-5928 Impact factor: 1.650